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Abstract
Background: Repeated apnoea events cause intermittent hypoxia (IH), which alters the function of various systems
and produces free radicals and oxidative stress.
Methods: We investigated hepatic oxidative stress in adult mice subjected to intermittent hypoxia, simulating
sleep apnoea. Three groups were submitted to 21 days of IH (IH-21), 35 days of IH (IH-35), or 35 days of sham IH.
We assessed the oxidative damage to lipids by TBARS and to DNA by comet assay; hepatic tissue inflammation
was assessed in HE-stained slides. Antioxidants were gauged by catalase, superoxide dismutase, glutathione
peroxidase activity and by total glutathione.
Results: After IH-21, no significant change was observed in hepatic oxidative stress. After IH-35, significant
oxidative stress, lipid peroxidation, DNA damage and reduction of endogenous antioxidants were detected.
Conclusions: In an animal model of sleep apnoea, intermittent hypoxia causes liver damage due to oxidative
stress after 35 days, but not after 21 days.
Background
In obstructive sleep apnoea (OSA), pharyngeal occlusion
occurs, typically for 10 to 40 seconds, causing a decrease
of PaO2 and an increase in PaCO2, ending with an arou-
sal [1]. Intermittent hypoxia due to OSA causes oxida-
tive stress, a recognized mechanism in the nonalcoholic
fatty liver disease (NAFLD), which may progress to non-
alcoholic steatohepatitis (NASH) [2].
Intermittent hypoxia (IH) increases liver damage [3].
During hypoxia, activation of xanthine oxidase [4],
NAPDH oxidase [5], and phospholipase A2 [6] occurs,
forming reactive oxygen species (ROS). Increased ROS
and decreased antioxidant capacity [7-9] induce oxida-
tive stress [10]. In hypoxia, superoxide anions are
formed, which, together with nitric oxide (NO), the
main vasodilator, produce peroxynitrite [11-13]. This
reaction reduces the bioavailability of NO, attenuating
NO-dependent vasodilation, capillary perfusion and
expression of adhesion molecules [14-17].
The formation of ROS in OSA is similar to what
occurs in ischemia-reperfusion [18]. Oxidative stress
leads to inflammation, recognised as a mechanism of
the pathophysiology of OSA [19]. Excessive formation of
ROS leads to lipid peroxidation in cell membranes, pro-
tein oxidation and DNA damage [20-22]. Several ROS
are formed in hepatocytes through the activation of
Kupffer cells and inflammatory cells [23].
Another group has exposed mice to IH and to a high-
cholesterol diet for 6 months, revealing the involvement
of OSA in non-alcoholic steatohepatitis (NASH) [3]. IH
aggravates paracetamol-induced liver damage after 21
days [24]. To understand the mechanisms leading to
NAFLD and NASH it may relevant to identify the time
frame in which these phenomena occur. There are, how-
ever, no studies specifically investigating the duration of
IH exposure that causes liver damage in an animal
model of sleep apnoea. This knowledge will be relevant
to help design future studies.
T h ea i mo ft h ep r e s e n ts t u d yw a st oe s t a b l i s ht h e
duration of exposure to intermittent hypoxia necessary
and sufficient to trigger liver damage and oxidative
stress in mice.
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The experimental procedures complied with the rules
established by the “Research in Health and Animal
Rights” according to the Commission of Research and
Ethics in Health of the Research and Postgraduate
Group of the Hospital de Clínicas de Porto Alegre.
Thirty-six male CF-1 mice (8-11 weeks old) from Fun-
dação Estadual de Produção e Pesquisa (FEPPS) were
employed. They were kept at the Animal Experimenta-
tion Unit of the Research Center of the Hospital de
Clínicas of Porto Alegre in plastic boxes measuring 30 ×
19 × 13 cm lined with wood chips, in a 12-hour dark/
light cycle (light from 7 a.m. to 7 p.m.) at a temperature
of 22 4°C. The mice were given food (Purina-Nutripal,
Porto Alegre, RS, Brazil) and water ad libitum.
The animals were randomly divided into three group-
ings (n = 12): group SIH, sham intermittent hypoxia,
which underwent the simulated procedure; group IH-21,
exposed to hypoxia for 21 days; and group IH-35,
exposed hypoxia for 35 days.
IH procedures were described in detail before [25]. In
brief, during five weeks, 7 days per week, 8 hours a day,
from 9 a.m. to 5 p.m., in the lights-on period, the rodents
were placed in the cages (Figure 1). A mixture with 90%
nitrogen and 10% CO2 was released in the hypoxia cham-
ber, for 30 seconds. The gas mixture reduced the oxygen
fraction from 21% to approximately 8% and the CO2 frac-
tion to 6%. Subsequently, a fan insufflated room air in the
chamber for 30 seconds, restoring the oxygen fraction to
21%. Each hypoxia/normoxia cycle lasted for 60 seconds;
in 8 hours, 480 IH periods occurred, equivalent to an
apnea index of 60 per hour.
The SIH group was housed in an adjacent cage and
underwent the same fan activity as the IH group, but no
gas was introduced in the cage during the hypoxia cycle
(Figure 1).
On the 21st or 35th day, the animals were killed. They
were first anaesthetised with ketamine hydrochloride
(100 mg/kg) and xylazine hydrochloride (50 mg/kg ip).
Blood was collected from the retro-orbital vein with the
aid of a heparinised glass capillary [26] to complete the
hepatic integrity (AST, ALT and ALP) test and comet
assay. We removed the liver of animals for histological
analysis; the rest were frozen -80°C for later biochemical
analysis. The animals were euthanized by exsanguination
under deep anaesthesia [27,28].
Nine millilitres of phosphate buffer (140 mM KCL, 20
mM phosphate, pH 7.4) per tissue gram was added, and
tissue was homogenised in an Ultra Turrax at 4°C. Next,
it was centrifuged for 10 minutes at 4,000 rpm (2150.4
g). The samples were stored again at -80°C for posterior
analyses.
We used the Bradford method to quantify protein,
with bovine albumin as the standard (Sigma
®). The
samples were measured spectrophotometrically at 595
nm, and values expressed in mg/g liver [29] were used
to calculate values of TBARS (thiobarbituric acid-reac-
tive substances) and antioxidant enzymes.
The amount of aldehydes generated by lipid peroxida-
tion is measured by the TBARS method, which mea-
sures the amount of substances reacting with
thiobarbituric acid. The samples were incubated at 100°
C for 30 minutes after addition of 0.37% thiobarbituric
acid in 15% trichloroacetic acid and centrifuged at 3000
rpm (1612.8 g) for 10 minutes at 4°C. Absorbance was
determined spectrophotometrically at 535 nm [30].
The analysis of SOD is based on the inhibition of the
reaction of the superoxide radical with adrenaline [31].
Figure 1 Diagram of the hypoxic and normoxic chambers. SV: solenoid valve; EF: exhaust fan; IF: insufflation fan.
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gressively inhibited by increasing amounts of SOD in
the homogenate, was monitored spectrophotometrically
at 480 nm. The amount of enzyme that inhibited 50% of
epinephrine auto-oxidation was defined as 1 U of SOD
activity.
The analysis of CAT activity is based on measuring
the decrease in hydrogen peroxide [32]. Catalase activity
was determined by measuring the decrease in absorption
at 240 nm in a reaction medium containing 50 mM
phosphate buffer saline (pH 7.2) and 0.3 M hydrogen
peroxide. The enzyme activity was assayed spectropho-
tometrically at 240 nm.
The activity of GPx is based on the consumption of
NADPH in the reduction of oxidised glutathione [33].
The glutathione peroxidase activity was determined by
the oxidation rate of NADPH in the presence of
reduced glutathione and glutathione reductase. Sodium
azide was added to inhibit catalase activity. The GPx
activity was measured with a spectrophotometer at 340
nm.
Total glutathione (GSH), a water soluble non-enzy-
matic antioxidant, [34] was measured as described pre-
viously [35], in a reaction medium consisting of a
solution of 300 mM phosphate buffer (Na2HPO4·1H2O)
and a solution of dithionitrobenzoic acid (DTNB). The
reaction products were read at 412 nm.
The alkaline comet assay was carried out as described
in [36], with minor modifications [37]. The liver tissue
samples (200-250 mg) were placed in 0.5 mL of cold
phosphate-buffered saline (PBS) and finely minced in
order to obtain a cell suspension; the blood samples (50
μL) were placed in 5 μL of anti-coagulant (heparin
sodium 25.000 UI- Liquemine
®). Liver and blood cell
suspensions (5 μL) were embedded in 95 μL of 0.75%
low melting point agarose (Gilco BRL) and spread on
agarose-precoated microated microscope slides. After
solidification, slides were placed in lysis buffer (2.5 M
NaCl, 100 mM EDTA an 10 mM Tris, pH 10.0), with
freshly added 1% Triton X-100 (Sigma) and 10% DMSO
for 48 h at 4°C. The slides were subsequently incubated
in freshly prepared alkaline buffer (300 mM NaOH and
1 mM EDTA, pH > 13) for 20 min, at 4°C. An electric
current of 300 mA and 25 V (0.90 V/cm) was applied
for 15 min to perform DNA electrophoresis. The slides
were then neutralized (0.4 M Tris, pH 7.5), stained with
silver and analyzed using microscope. Images of 100
randomly select cells (50 cells from each of two replicate
slides) were analyzed from each animal. Cells were also
visually scored according to tail size into five classes
ranging from undamaged (0) to maximally damage (4),
resulting in a single DNA damage score to each animal,
and consequently to each studied group. Therefore, the
damage index (DI) can range from 0 (completely
undamaged, 100 cells × 0) to 400 (with maximum
damage, 100 × 4). Damage frequency (%) was calculated
based on the number of tailed versus tailless cells.
The levels of nitrates and nitrites were measured by
the reaction of the samples with Griess reagent. Aliquots
of 50 μL were incubated with enzyme cofactors and
nitrate reductase for 30 minutes at room temperature
for the conversion of nitrate to nitrite. The nitrite
formed was then analysed by reaction with the Griess
reagent, forming a coloured compound that was mea-
sured by spectrophotometer at a wavelength of 540 nm
[38].
For histological evaluation, part of the liver was pre-
served in 10% formalin for 24 hours, embedded in paraf-
fin, and cut into 6-μm thick sections with a microtome.
Sections were stained with hematoxylin and eosin.
The results are expressed as mean ± standard error.
We used ANOVA and the Student-Newmann-Keuls or
Student’s t-test for comparing groups. The significance
level was 5% (p < 0.05).
Results
The circulating levels of the liver enzymes aspartate
aminotransferase (AST), alanine amino transferase
(ALT), and alkaline phosphatase (ALP), parameters of
liver damage, showed no significant difference between
the IH-21 group and the SIH. The IH-35 group showed
significantly increased levels (p < 0.05) compared to the
sham intermittent hypoxia group (Table 1).
Lipid peroxidation measured by the TBARS technique
showed no oxidative damage in group IH-21 compared
to SIH. However, there was significant damage in the
lipid peroxidation in liver subjected to hypoxia for 35
days (Figure 2). Evaluation of the antioxidant enzymes
showed a significant decrease in the activities of super-
oxide dismutase (SOD), glutathione peroxidase (GPx)
and catalase (CAT) in liver tissue with intermittent
hypoxia for 35 days (Table 2). The quantification of
total endogenous glutathione in the liver showed a sig-
nificant decrease in the 35-day hypoxia group compared
with the sham intermittent hypoxia (Figure 3). These
results demonstrate that IH induced a decrease in the
endogenous antioxidant defence.
Table 1 Enzymes indicating hepatic integrity: AST, ALT
and alkaline phosphatase.
Enzymes SIH IH-21 IH-35
AST (U/L) 124.4 ± 6.5 94.36 ± 7.05 145.8 ± 7.2
a
ALT (U/L) 45.5 ± 4.0 48.50 ± 2.85 55.6 ± 1.3
b
AP (U/L) 97.7 ± 3.1 84.25 ± 1.98 122.6 ± 2.4
c
Data are presented as mean ± standard error (n = 12 animals/group).
a IH-35
vs SIH, p = 0,04;
b IH-35 vs SIH, p = 0,03;
c IH-35 vs SIH, p < 0,0001. SIH: sham
intermittent hypoxia group; IH-21: intermittent hypoxia for 21 days; IH-35:
intermittent hypoxia for 35 days; AST: aspartate aminotransferase; ALT: alanine
aminotransferase; ALP: alkaline phosphatase.
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showed that the damage in blood did not differ between
groups, but the liver tissue exhibited a significant
increase in DNA damage in group IH-35 compared with
SIH (Table 3).
In the assessment of metabolites of nitric oxide in
liver tissue of mice subjected to IH for 35 days, we
noted a significant increase in NO in these animals
compared with SIH (Table 4).
Several histological liver changes were also observed in
animals of the IH-35 group - ballooning, steatosis,
necrosis and the presence of neutrophils -when com-
pared with mice under sham intermittent hypoxia (Fig-
ures 4 and 5).
Discussion
We report for the first time that 35 but not 21 days of
exposure to IH, simulating an OSA of 60 events per
hour, reducing for 6% the concentration of oxygen,
causes hepatic damage. This is also the first report to
combine the description of enzyme, lipid, DNA, oxida-
tive, and nitrosative hepatic damage. We used an experi-
mental model that produces levels of hypoxia
comparable to those observed in patients with severe
OSA [24,39]. Although our findings cannot be immedi-
ately translated to the clinical setting, they are in agree-
ment with the literature indicating an OSA-NASH
association [40,41].
Two mechanisms are proposed for the morbidity
caused by OSA: the activation of inflammatory factors
and oxidative stress [42,43], which also can be modu-
lated by genetic, lifestyle and environmental factors
[43,44]. Oxidative stress plays an important role in var-
ious diseases as well as in OSA, which causes an effect
similar to ischemia-reperfusion [18] in which there is
activation of xanthine oxidase, leading to the formation
free radicals and further imbalance between oxidants
and antioxidants [4-6].
The analysis of liver integrity showed that the liver tis-
sue of mice subjected to intermittent hypoxia was
damaged, but only after 35 days, as demonstrated by the
significant increase in circulating AST, ALT and alkaline
phosphatase. The present results demonstrate damage
both at cytoplasmic and mitochondrial level, confirmed
by the presence in the histological examination of bal-
looning, steatosis, necrosis and the presence of neutro-
phils in the liver, similar to what is observed in NASH
[45].
In the evaluation of hepatic lipid peroxidation, we
observed a significant increase in lipid oxidative damage
in animals that were subjected to hypoxia for 35 days,
as indicated by the TBARS test, but not in group IH-21.
Figure 2 Effect of intermittent hypoxia on hepatic lipid
peroxidation, evaluated using the TBARS assay. Data are mean
± standard error of the mean (n = 12 animals/group).
a, p = 0.0182
vs. SIH. SIH: sham intermittent hypoxia group; IH-21: intermittent
hypoxia for 21 days; IH-35: intermittent hypoxia for 35 days.
Table 2 Activities of liver antioxidant enzymes
Enzymes SIH IH-35 p value
SOD (USOD/mg prot) 4.63 ± 0.26 3.16 ± 0.25 0.0005
GPx (mmol/min/mg prot) 1.00 ± 0.11 0.52 ± 0.06 0.0028
CAT (pmol/mg prot) 1.06 ± 0.04 0.79 ± 0.03 0.0003
Data are mean ± standard error (n = 12 animals/group). SIH: sham
intermittent hypoxia group; IH-35: intermittent hypoxia for 35 days. SOD:
superoxide dismutase; GPx: glutathione peroxidase; CAT: catalase.
Figure 3 Effect of intermittent hypoxia on total liver
glutathione. Data are mean ± standard error of the mean (n = 12
animals/group).
a, p = 0.0008 vs. SIH. SIH: sham intermittent hypoxia
group; IH-35: intermittent hypoxia for 35 days.
Table 3 Comet assay on peripheral blood and liver
tissues from mice subjected to hypoxia
SIH IH-35
Tissue Damage
index
a
Damage
frequency
b
Damage
index
Damage
frequency
Blood 15.3 ± 4.4 7.6 ± 1.3 19.3 ± 4.1 8.0 ± 1.4
Liver 38.1 ± 5.1 14.8 ± 1.8 114.7 ± 32.3** 43.2 ± 11.3**
Data are presented as mean ± standard error (n = 6 animals/group). SIH:
sham intermittent hypoxia group; IH-35: intermittent hypoxia for 35 days.
a,
Damage index: can range from 0 (completely undamaged, 100 cells × 0) to
400 (with maximum damage, 100 × 4).
b, Damage frequency: calculated based
on the number of cells with tails versus those with no tail. **, p < 0.01,
statistically significant difference from sham intermittent hypoxia group
(t-test).
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cals in the liver tissue. Similar data have been reported
in other studies of intermittent hypoxia [46-48] and by
our laboratory in other experimental models of hepatic
oxidative damage [49-54].
As we did not observe liver damage in animals
exposed to IH for 21 days, by the liver enzyme, histolo-
gical, or lipid peroxidation assays, we concluded that
this duration of IH causes no damage to the organ.
Therefore, dosages of antioxidant enzymes, comet assay
and nitrites metabolites were not conducted in the IH
21 group.
Comet assay in liver tissue revealed a significant
increase in DNA damage in the IH-35 group in compar-
ison to the SIH group. No evidence of damage was
observed in blood tissue. The rate of DNA damage
detected by the comet assay depends on the tissue or
organ analyzed [55]. Here, the DNA damage was
observed only in the tissue most susceptible to lesions
produced by IH. In the alkaline version used, the comet
assay detects a broad spectrum of DNA lesions, includ-
ing single strand breaks [56,57].
Previous comet assay and TBARS data have demon-
strated increased formation of free radicals in sleep
apnoea patients [11]. Possibly, the formation of superox-
ide radical (O2
-￿) and hydrogen peroxide (H2O2), which
appear to be increased in individuals with OSA, is due
to the conversion of xanthine dehydrogenase (type D)
into its oxidase (type O) form in hypoxia, followed by
the activation of the oxidase form during reoxygenation
(normoxia) by the hypoxanthine formed during hypoxia.
This xanthine oxidase activity generates O2
-￿,H 2O2, and
uric acid [4,11].
Our evaluation of the endogenous antioxidant liver
enzymes SOD, GPx and CAT showed that their activ-
ities were significantly decreased in mice after 35 days
under intermittent hypoxia. Quantification of total glu-
tathione revealed significant decreases in the group
exposed to intermittent hypoxia compared to SIH,
demonstrating a reduced hepatic antioxidant defence in
these animals.
The increase in TBARS and decrease in endogenous
antioxidants observed in the present study further pro-
motes oxidative stress, contributing to aggravation of the
liver tissue injury. This kind of pathological synergy is evi-
denced in experimental models of liver damage induced
by xenobiotic agents that cause oxidative stress such as
carbon tetrachloride and toluene [49,50,52,54,58], by sur-
gical procedures such as ligation of the common bile duct
[51,53] or by thymoquinone [59].
The increased nitric oxide metabolites nitrite and
n i t r a t ei nt h el i v e r so fI H - 3 5m i c ec o n f i r m sf i n d i n g sb y
other authors, who demonstrated a significant increase
of nitric oxide in animals exposed to IH simulating
OSA (6 min/6 min) during 120 days [48], and to hypo-
baric hypoxia during 32 days [60]. The increase of NO,
along with increased free radicals, may generate nitro-
sative stress caused by the reaction products of these
two substances, such as peroxide nitrite (OONO
￿)
formed by the reaction between NO and O2
-￿ [11].
Much evidence indicates that oxidative and nitrosative
Table 4 Quantification of nitric oxide metabolites in liver
tissue
Metabolites SIH IH-35 p value
NO2(μmol/L) 2.128 ± 0.202 3.405 ± 0.112 0.0001
NO3(μmol/L) 0.018 ± 0.002 0.050 ± 0.003 0.0001
Data are mean ± standard error of the mean (n = 12 animals/group). SIH:
sham intermittent hypoxia group; IH-35: intermittent hypoxia for 35 days; NO2:
total nitrate; NO3: nitrites.
Figure 4 Photomicrograph of the mouse liver in sham
intermittent hypoxia condition. A normal histological pattern was
observed. Hematoxylin and eosin.
Figure 5 Photomicrograph of the mouse liver in intermittent
hypoxia for 35 days. It was observed cellular ballooning, steatosis,
necrosis and the presence of neutrophils. Hematoxylin and eosin.
Rosa et al. Comparative Hepatology 2011, 10:1
http://www.comparative-hepatology.com/content/10/1/1
Page 5 of 7stress have important roles in the complication of
hypoxia [61].
OSA is usually accompanied by arterial hypertension,
pulmonary hypertension, myocardial infarction and
stroke, which may be due to changes in nitric oxide pro-
duction [62]. Veasey et al. had demonstrated irreversible
basal forebrain nitrosative damage as a possible cause
for residual sleepiness in OSA [63].
It is increasingly clear that IH is capable of causing
liver tissue damage. This was here demonstrated by sev-
eral lines of evidence: elevated circulating levels of liver
enzymes, NO increase, damage to lipids and DNA, and
reduced endogenous antioxidant defences. Further
translational research is necessary to completely corre-
late these findings with the NASH pathology.
Conclusions
The present results suggest that a model of intermittent
hypoxia for 35 days, simulating sleep apnoea, is useful
to investigate liver injury by oxidative and nitrosative
stress. Exposure to intermittent hypoxia during 21 days
may be insufficient to produce hepatic damage.
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